Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1254 of 5804
-
New cream trio aims to outshine standard melasma treatment
Disease control CompletedThe goal of this clinical trial is to learn if the drug New Trio Combination (0.1% isobutylamido-thiazolyl-resorcinol, 0.1% retinoic acid and 0.1% dexamethasone) works to treat melasma. It will also learn about the safety of drug. This drug lowers the pigmentation severity by mea…
Phase: PHASE4 • Sponsor: Ghurki Trust and Teaching Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a tiny zap save your sight? new device trial for dry AMD
Disease control Recruiting nowThe goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in patients with intermediate to advanced nonexudative AMD. Participants will: * Undergo an initial loading regimen, followed by 7 m…
Phase: NA • Sponsor: i-Lumen Scientific AUS PTY LTD • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Common diabetes drug may shield kidneys from chemo damage
Disease control Recruiting nowPatients with cancer who receive platinum-based chemotherapy are at increased risk of kidney injury caused by these drugs. This form of toxicity can lead to treatment delays, dose reductions, or permanent discontinuation of chemotherapy, all of which can negatively impact cancer …
Phase: PHASE2 • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
No-Needle cancer test: ultrasound reads tumor type
Diagnosis CompletedPurpose: This study aims to develop a non-invasive method to distinguish between luminal and non-luminal breast cancer subtypes using super-resolution ultrasound (SRUS). Currently, subtype classification requires a tissue biopsy, which is invasive and may not fully capture the tu…
Sponsor: Anhui Provincial Cancer Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
Can baking soda help women in prolonged labor? uganda trial seeks answers
Disease control CompletedThe goal of this clinical trial is to determine a universal safe and effective dose of sodium bicarbonate for use among women with Obstructed labour to treat acidosis. It will also learn about the safety of sodium bicarbonate drug among women with Obstructed labour. Researchers …
Phase: PHASE3 • Sponsor: Busitema University • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Can a simple hormone pill help prevent early delivery?
Disease control CompletedPreterm labor, which occurs when labor starts before 37 weeks of pregnancy, is a major cause of illness and death in newborns. Babies born too early are at higher risk of breathing problems, low birth weight, infections, and other complications. Treatments that safely delay deliv…
Phase: PHASE4 • Sponsor: Medicare Hospital (Pvt) Limited • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Trauma recovery showdown: therapy vs. pills for PTSD growth
Symptom relief CompletedThis randomized controlled trial investigates the comparative effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy and selective serotonin reuptake inhibitors (SSRIs) in fostering post-traumatic growth among patients diagnosed with post-traumatic stress d…
Phase: NA • Sponsor: Asad Ullah Jan • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New stent aims to cut bleeding risk for heart patients on blood thinners
Disease control Recruiting nowPatients receiving chronic oral anticoagulation with indication for percutaneous coronary revascularization with stent implantation, and needing for antiplatelet therapy, are at high risk of bleeding. The new generation of ultrathin strut sirolimus-eluting stent with bioabsorbabl…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill combo challenges standard antidepressants in Head-to-Head trial
Symptom relief CompletedThe study aims to compare the antidepressant effects of a dextromethorphan-bupropion combination versus standard SSRI therapy in adult patients with major depressive disorder. Participants will be randomized into two groups: one receiving dextromethorphan-bupropion and the other …
Phase: NA • Sponsor: Asad Ullah Jan • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can a Stop-Smoking drug also curb cannabis? new trial aims to find out
Disease control Recruiting nowThe purpose of the RECLAIM study is to evaluate the effectiveness of varenicline (sometimes known as Chantix) compared to placebo (an inactive substance) for the treatment of cigarettes and cannabis (marijuana). Varenicline is not FDA approved for the combination treatment of cig…
Phase: PHASE3 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New heart valve study aims to improve life for High-Risk patients
Disease control Recruiting nowThis is a prospective, single-arm, multi-center, observational, post-market registry to document the clinical safety and performance of MicroPort CardioFlow VitaFlow Liberty™ Transcatheter Aortic Valve System in the routine practice for the treatment of severe aortic valve stenos…
Sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a common hormone beat dangerous Post-Surgery low blood pressure?
Disease control Recruiting nowThe purpose of this research is to evaluate the use of Angiotensin II in patients with low blood pressure post-surgery. Your information will be collected for 28 days post the procedure and initiation of the study drug to assess for safety events and complications.
Phase: PHASE4 • Sponsor: University of Maryland St. Joseph Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Virtual reality workouts could ease fibromyalgia pain
Symptom relief Recruiting nowThe primary aim of this randomized controlled trial is to determine the efficacy of a 6-week immersive virtual reality (IVR)-based therapeutic exercise intervention, which manipulates visual proprioceptive input during exercise, for patients diagnosed with fibromyalgia (FM). Part…
Phase: NA • Sponsor: Cardenal Herrera University • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Could a diabetes drug curb alcohol cravings in schizophrenia?
Disease control Recruiting nowGlucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for the treatment of type 2 diabetes and obesity, have shown promise as a novel treatment for alcohol use disorder (AUD). This study aims to investigate whether the Glucose-dependent Insulinotropic Polypeptide/GLP-1RA…
Phase: PHASE2 • Sponsor: Anders Fink-Jensen, MD, DMSci • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Smart insulin system could ease diabetes management for type 2 patients
Disease control Recruiting nowThe aim of the study is to compare, in a population of patients with type 2 diabetes, open-loop insulin pump treatment with the CamAPS HX (Camdiab) Fully Closed Loop Automated Insulin Therapy system, on the efficacy and safety of use of the Fully Closed Loop, as well as on psycho…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early phase oncology trial will be conducted at various study centers to investigate the safety, tolerability, and antitumor activity of STC-15 (a METTL3 inhibitor) in combination with toripalimab (anti- programmed cell death 1 \[PD-1\]) in advanced unresectable or metastati…
Phase: PHASE1, PHASE2 • Sponsor: STORM Therapeutics LTD • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New antibody drug aims to slow lung scarring in IPF
Disease control Recruiting nowA Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Phase: PHASE2 • Sponsor: Mediar Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New combo therapy aims to treat prostate cancer with fewer side effects
Disease control Recruiting nowThe purpose of this research is to gather information on the safety and effectiveness of combining focal prostate ablation therapy ((aka Focal Therapy, a surgical procedure) and androgen deprivation therapy (hormone therapy).
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental antibody aims to stabilize blood pressure in sepsis patients
Disease control CompletedThis study is researching an experimental drug called REGN7544 (called "study drug"). The study is focused on adult patients (18 to 85 years) hospitalized due to a serious infection (called "sepsis") and receiving standard-of-care medications for low blood pressure (called "vasop…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New radiation approach targets cancer in the brain and spine
Disease control Recruiting nowThis phase II trial tests how well craniospinal irradiation (CSI) using photon volumetric modulated arc radiotherapy (VMAT) works in treating patients with breast cancer or non-small cell lung cancer (NSCLC) that has spread from the original (primary) tumor to the cerebrospinal f…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC